Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia

This study is currently recruiting participants.
Verified March 2012 by University Health Network, Toronto
Sponsor:
Collaborators:
University of Kansas
Memorial Sloan-Kettering Cancer Center
University of California, Los Angeles
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01332786
First received: March 31, 2011
Last updated: March 16, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)